CNS Tumors

CNS Tumors

by Roy Strowd, MD

A CNS tumor begins when healthy cells within the brain or the spinal cord change and grow out of control, forming a mass. Though such tumors are not acutely life-threatening, they are life-threatening illnesses nonetheless.

A CNS tumor can be either cancerous or benign. A cancerous tumor has the potential to grow quickly and metastasize, whereas a benign tumor is slow-growing and lacks the biological capability to metastasize. Both types are potentially dangerous.

Understanding the basic anatomy of the brain is vital for recognizing the signs and symptoms of CNS tumors early on. For example, a tumor in the frontal lobe might impair reasoning, emotions, problem-solving, and parts of speech and movement, while a parietal lobe tumor might impair sensations of pressure, temperature, pain, and touch. It is also important to recognize the risk factors, epidemiology, and more nonspecific signs of brain tumors—including signs of increased intracranial pressure—and how to perform a general neurological exam to localize the lesion. In addition, recognizing syndromic associations may be crucial for early identification of diseases such as neurofibromatosis and tuberous sclerosis.

Recognizing the type of tumor and obtaining pathologic/imaging findings (grade) are vital for understanding how fast the tumor will grow, and thus for determining the management approach. Although the treatment of these tumors is complicated, any clinician should have a general understanding of the various treatment modalities available, including surgery, chemotherapy, and radiotherapy.

Course Details

  • Videos 37
  • Duration 2:40 h
  • Quiz questions 87
  • Concept Pages 14


Your Educators of course CNS Tumors

 Roy Strowd, MD

Roy Strowd, MD

Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.

User reviews

5,0 of 5 stars
5 Stars
4 Stars
3 Stars
2 Stars
1  Star
Great class
By Maria Jose M. on 03. December 2023 for CNS Tumors

Excellent information to update your knowledge. The hints are useful.

Easy to remember
By Alaena A. on 29. September 2022 for Neurofibromatosis Type 1: Diagnosing Criteria

I like that NF-1 and NF-2 are compared on the same slide.

By Alaena A. on 29. September 2022 for Neurofibromatosis Type 1: Introduction

Very clear review of NF-1. It's a lot better than the other lecture.